Gene expression pattern in canine mammary osteosarcoma

Polish Journal of Veterinary Sciences

Volumn 14, Issue 1, 2011, Pages 11-20

  Pawlowski K M ^a   Majewska, A ^a   Szyszko, K ^a   Dolka, I ^a   Motyl, T ^a   Krol M ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Canine mammary osteosarcoma; Gene expression; Microarray; Transcriptome

Indexed keywords

RNA;

ANIMAL; ARTICLE; DOG; DOG DISEASE; DOWN REGULATION; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OSTEOSARCOMA; PHYSIOLOGY; POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; DOG DISEASES; DOGS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, ANIMAL; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; RNA; UP-REGULATION;

EID: 79953720259     PISSN: 15051773     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10181-011-0002-2     Document Type: Article

References (43)

1. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B[alpha]. Curr Biol 7: 261-269. (Pubitemid 27176852)
2. Alessi DR, Kozlowski MT, Weng QP, Morrice N, Avruch J (1998) 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol 8: 69-81. (Pubitemid 28104519)
3. Balendran A, Hare GR, Kieloch A, Williams MR, Alessi DR (2000) Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett 484: 217-223.
4. Bordeleau ME, Cencic R, Lindqvist L, Oberer M, Northcote P, Wagner G, Pelletie J (2006) RNA-mediated sequestration of the RNA helicase eIF4A by pateamine A inhibits translation initiation. Chem Biol 13: 1287-1295. (Pubitemid 44932234)
5. Brinkhof B, Spee B, Rothuizen J, Penning LC (2006) Development and evaluation of canine reference genes for accurate quantification of gene expression. Anal Biochem 356: 36-43. (Pubitemid 44232736)
6. Cen L, Hsieh FC, Lin HJ, Chen CS, Qualman SJ, Lin J (2007) PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound. Br J Cancer 97: 785-791.
7. Clark AS, West K, Streicher S, Dennis PA (2002) Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol Cancer Ther 1: 707-717.
8. Cooper ML, Adami HO, Gronberg H, Wiklund F, Green FR, Rayman MP (2008) Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res 68: 10171-10177.
9. Etschmann B, Wilcken, B, Stoevesand K, von der Schulenburg A, Sterner-Kock A (2006) Selection of reference genes for quantitative real-time PCR analysis in canine mammary tumors using the GeNorm algorithm. Vet Pathol 43: 934-942. (Pubitemid 44785966)
10. Gartner F, Geraldes M, Cassali G, Rema A, Schmitt F (1999) DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis. Vet J 158: 39-47. (Pubitemid 129524825)
11. Gresner P, Gromadzinska J, Jablonska E, Kaczmarski J, Wasowicz W (2009) Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer. Lung Cancer 65: 34-40.
12. Hellmen E, Bergstrom R, Holmberg L, Spangberg IB, Hansson K, Lindgren A (1993) Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases. Vet Pathol 30: 20-27.
13. Hellmen E, Moller M, Blankenstein MA, Andersson L, Westermark B (2000) Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin. Breast Cancer Res Treat 61: 197-210. (Pubitemid 30609553)
14. Król M, Pawlowski KM, Skierski J, Rao NA, Hellmen E, Mol JA, Motyl T (2009) Transcriptomic profile of two canine mammary cancer cell lines with different proliferative and anti-apoptotic potential. J Physiol Pharmacol 60: 95-106.
15. Król M, Polanská J, Pawłowski KM, Turowski P, Skierski J, Majewska A, Ugorski M, Morty RE, Motyl T (2010a) Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungs. J Appl Genet 51: 37-50.
16. Król M, Pawlowski KM, Skierski J, Turowski P, Majewska A, Polanská J, Ugorski M, Morty RE, Motyl T (2010b) Transcriptomic "portraits" of canine mammary cancer cell lines with various phenotypes. J Appl Genet 51: 169-183.
17. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ (1998) Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281: 2042-2045. (Pubitemid 28475494)
18. Leibl S, Moinfar F (2006) Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation. Am J Surg Pathol 30: 450-456. (Pubitemid 43740145)
19. Levine RE, Forest T, Smith C (2002) Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors. Vet Pathol 39: 372-378.
20. Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW, Sonenberg N (2004) eIF4E - from translation to transformation. Oncogene 23: 3172-3179. (Pubitemid 38638828)
21. Maurer M, Su T, Saal LH, Koujak S, Hopkins BD, Barkley CR, Wu J, Nandula S, Dutta B, Xie Y, Chin YR, Kim DI, Ferris JS, Gruvberger-Saal SK, Laakso M, Wang X, Memeo L, Rojtman A, Matos T, Yu JS, Cordon-Cardo C, Isola J, Terry MB, Toker A, Mills GB, Zhao JJ, Murty VV, Hibshoosh H, Parsons R (2009) 3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma. Cancer Res 69: 6299-6306.
22. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, Guo N, Muruganujan A, Doremieux O, Campbell MJ, Kitano H, Thomas PD (2005) The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 33: D284-288.
23. de los Monteros AE, Millan MY, Ramirez GA, Ordas J, Reymundo C, de las Mulas JM (2005) Expression of maspin in mammary gland tumors of the dog. Vet Pathol 42: 250-257.
24. Mora A, Komander D, van Aalten DM, Alessi DR (2004) PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 15: 161-170. (Pubitemid 38251644)
25. Nesterov A, Lu X, Johnson M, Miller GJ, Ivanshchenko Y, Kraft AS (2001) Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem 276: 10767-10774. (Pubitemid 38089250)
26. Page C, Lin HJ, Jin Y, Castle VP, Nunez G, Huang M, Lin J (2000) Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis. Anticancer Res 20: 407-416. (Pubitemid 30189787)
27. Pawłowski KM, Król M, Majewska A, Badowska-Kozakiewicz A, Mol JA, Malička E, Motyl T (2009) Comparison of cellular and tissue transcriptional profiles in canine mammary tumor. J Physiol Pharmacol 60: 85-94.
28. Pilar S, Clement V, Ruiz i Altaba A (2005) Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer. Cancer Res 65: 2990-2992.
29. Polyak K (2007) Breast cancer: origins and evolution. J Clin Invest 117: 3155-3163.
30. Rao NA, van Wolferen ME, van den Ham R, van Leenen D, Groot Koerkamp MJ, Holstege FC, Mol JA (2008) cDNA microarray profiles of canine mammary tumor cell lines reveal deregulated pathways pertaining to their phenotype. Anim Genet 39: 333-345. (Pubitemid 351989267)
31. Rao NA, van Wolferen ME, Gracanin A, Bhatti SF, Król M, Holstege FC, Mol JA (2009) Gene expression profiles of progestin-induced canine mammary hyperplasia and spontaneous mammary tumors. J Physiol Pharmacol 60: 73-84.
32. Rogers GW Jr, Richter NJ, Lima WF, Merrick WC (2001) Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F. J Biol Chem 276: 30914-30922.
33. Sobczak-Filipiak M, Malička E (2002) Estrogen receptors in canine mammary gland tumours. Pol J Vet Sci 5: 1-5.
34. Stecca B, Mas C, Clement V, Zbinden M, Correa R, Piguet V, Beermann F, Ruiz I Altaba A (2007) Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sei USA 104: 5895-5900. (Pubitemid 47175630)
35. Stecca B, Ruiz I Altaba A (2010) Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. J Mol Cell Biol 2: 84-95.
36. Stokoe D, Stephens LR, Copeland T, Gaffney PR, Reese CB, Painter GF, Holmes AB, McCormick F, Hawkins PT (1997) Dual role of phosphatidylinositol-3,4, 5-trisphosphate in the activation of protein kinase B. Science 277: 567-570. (Pubitemid 27369005)
37. Trent S, Yang C, Li C, Lynch M, Schmidt EV (2007) Heat shock protein B8, a cyclin-dependent kinase-independent cyclin D1 target gene, contributes to its effects on radiation sensitivity. Cancer Res 67: 10774-10781. (Pubitemid 350145905)
38. Vogelstein B, Kinzler KW (2004) Cancer genes and the pathways they control. Nat Med 10: 789-799. (Pubitemid 39070849)
39. Wensman H, Goransson H, Leuchowius KJ, Stromberg S, Ponten F, Isaksson A, Rutteman GR, Heldin NE, Pejler G, Hellmen E (2009) Extensive expression of craniofacial related homeobox genes in canine mammary sarcomas. Breast Cancer Res Treat 118: 333-343.
40. Xie Z, Zeng X, Waldman T, Glazer RI (2003) Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1. Cancer Res 63: 5370-5375.
41. Xie Z, Yuan H, Yin Y, Zeng X, Bai R, Glazer RI (2006) 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases. BMC Cancer 6: 77.
42. Zeng X, Xu H, Glazer RI (2002) Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase C alpha. Cancer Res 62: 3538-3543. (Pubitemid 34651405)
43. Zeynep ME, Kieser KJ, Kim SH, Komm B, Katzenellenbogen JS, Katzenellenbogen BS (2008) Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol 22: 2116-2127.